Ibrain (Jun 2021)

New progress of isoflurane, sevoflurane and propofol in hypoxic‐ischemic brain injury and related molecular mechanisms based on p75 neurotrophic factor receptor

  • Yi Zhu,
  • Hong‐Su Zhou,
  • Dong‐Qin Chen,
  • Di Zhou,
  • Nan Zhao,
  • Liu‐Lin Xiong,
  • Issac Deng,
  • Xin‐Fu Zhou,
  • Zhao‐Qiong Zhu

DOI
https://doi.org/10.1002/j.2769-2795.2021.tb00075.x
Journal volume & issue
Vol. 7, no. 2
pp. 132 – 140

Abstract

Read online

Hypoxic ischemic brain injury (HIBI) is one of the most common clinical disorders, especially in neonates. The complex pathophysiology of HIBI is an important cause of disability and even death of patients, however, being without effective clinical treatments. Common anesthetics (such as isoflurane, propofol and sevoflurane) have an adverse impact on neuronal cells for HIBI via the regulation of p75 neurotrophic factor receptor (P75NTR). In order to protect the injured brains and study the effect of underlying treatments, it is particularly significant to understand and master the developmental mechanism of anesthetics for the occurrence of HIBI related molecular mechanisms. Therefore, this paper will mainly review the corresponding pathogenic and protective mechanisms about HIBI binding to the research progress of the role of P75NTR. In conclusion, the effects of neuroprotection and injured nerves are involved in the expression and activation of P75NTR, mainly increased P75NTR mRNA, protein levels and calpain‐dependent for propofol, and inducing neuronal apoptosis for isoflurane and sevoflurane, and we look forward to that connection with P75NTR, common anaesthetic and HIBI may be a new direction of research and gain perfect outcomes in the future.

Keywords